Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,141,625
-$4,890,719 QoQ
Shares Held
549,830
-44.5% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#45
of 290 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. DNLI ranks #55 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in DNLI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,141,625 | 549,830 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $19,032,344 | 991,268 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $12,611,856 | 763,892 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $11,427,661 | 787,029 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $19,659,447 | 1,405,250 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $29,751,597 | 2,188,422 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $36,454,460 | 1,788,737 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $57,302,817 | 1,967,141 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $56,165,302 | 2,418,833 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $44,043,697 | 2,146,379 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $35,782,339 | 1,667,397 | Shares | Other | 2024-02-14 | |
| 2023-03-31 | $8,076,418 | 350,539 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $26,715,370 | 960,639 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $20,742,450 | 675,870 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $24,063,439 | 817,650 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $4,917,345 | 152,855 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $17,123,902 | 383,944 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $26,807,011 | 531,358 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $50,672,161 | 645,999 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,682,477 | 99,518 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $11,650,769 | 325,168 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $932,622 | 38,570 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,239,521 | 242,120 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||